Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −4 vs. Q1 2022
- Shares held
- 13.0M
- −2.04M (−13.6%) vs. Q1 2022
- Total value
- $3.51M
- −$4.91M (−58.4%) vs. Q1 2022
- New holders
- 3
- 5 more added
- Sold out
- 7
- 13 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $34.7M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,822,193 | $762.0K | 0.00% | 00.0% | Unchanged |
| Menora Mivtachim Holdings Ltd. | 2,094,208 | $565.0K | 0.01% | 00.0% | Unchanged |
| American Financial Group Inc | 1,480,000 | $400.0K | 0.13% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $318.0K | 0.01% | 00.0% | Unchanged |
| Altshuler Shaham Ltd | 1,077,661 | $291.0K | 0.00% | −11,187−1.0% | Reduced |
| Silverarc Capital Management, LLC | 1,041,499 | $281.0K | 0.13% | −909,450−46.6% | Reduced |
| Geode Capital Management, LLC | 802,413 | $214.0K | 0.00% | +2,080+0.3% | Added |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $158.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 358,678 | $97.0K | 0.00% | −142,905−28.5% | Reduced |
| Bridgeway Capital Management, LLC | 249,400 | $67.0K | 0.00% | −60,000−19.4% | Reduced |
| State Street Corp | 189,959 | $51.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 179,400 | $48.0K | 0.00% | +179,400 | New |
| Vanguard Capital Wealth Advisors | 155,900 | $41.0K | 0.05% | −3,000−1.9% | Reduced |
| Bank of New York Mellon Corp | 145,381 | $39.0K | 0.00% | −910−0.6% | Reduced |
| Atom Investors LP | 129,116 | $35.0K | 0.02% | +15,965+14.1% | Added |
| Northern Trust Corp | 123,669 | $33.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 111,760 | $30.0K | 0.00% | +111,760 | New |
| Bank of America Corp | 58,089 | $16.0K | 0.00% | −124−0.2% | Reduced |
| Two Sigma Advisers, LP | 49,300 | $13.0K | 0.00% | −184,100−78.9% | Reduced |
| Wells Fargo & Company | 46,706 | $13.0K | 0.00% | +34+0.1% | Added |
| B. Riley Wealth Management, Inc. | 37,500 | $10.0K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 39,675 | $10.0K | 0.00% | +11,144+39.1% | Added |
| D. E. Shaw & Co., Inc. | 21,295 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,015 | $4.00K | 0.00% | +11,476+745.7% | Added |
| Advisor Group Holdings, Inc. | 12,359 | $3.00K | 0.00% | −1,000−7.5% | Reduced |
| Morgan Stanley | 3,180 | $1.00K | 0.00% | −2,452−43.5% | Reduced |
| BNP Paribas Arbitrage, SA | 489 | $132 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 179 | $0 | 0.00% | −78,717−99.8% | Reduced |
| JPMorgan Chase & Co | 41 | $0 | 0.00% | −581−93.4% | Reduced |
| National Bank of Canada | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 60 | $0 | 0.00% | −704−92.1% | Reduced |
| Credit Suisse AG | 5 | $0 | 0.00% | +5 | New |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −774,767−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −105,883−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −23,079−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −21,849−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,504−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,354−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,860−100.0% | Sold out |